Bone and Joint Diseases
Bone and Joint Diseases is a research topic within Orthopedics and Sports Medicine. Science Explorer counts 28k research works in it since 1950. 14.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the pathogenesis, natural history, and treatment of osteonecrosis, particularly in the femoral head. It covers topics such as the use of stem cell therapy, core decompression, glucocorticoid-induced osteonecrosis, and the role of bone marrow in the development and diagnosis of osteonecrosis. MRI imaging is also explored for its insights into the condition.
- Osteonecrosis
- Femoral Head
- Bone Marrow
- Treatment
- Pathophysiology
- MRI Imaging
- Core Decompression
- Stem Cell Therapy
- Glucocorticoid-induced
- Avascular Necrosis
- Research works
- 28k fractional, since 1950
- In the world top 10%
- 4.1k per year above
- Top-10% rate
- 14.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +12% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Bone and Joint Diseases research?
By volume, China and the United States publish the most (941 and 872 works in 2022–2025).
By volume, 2022–2025
- 1 China 941 works
- 2 United States 872 works
- 3 Japan 287 works
- 4 India 268 works
- 5 Germany 173 works
- 6 United Kingdom 171 works
- 7 Türkiye 153 works
- 8 South Korea 148 works
- 9 Italy 145 works
- 10 France 125 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Bone and Joint Diseases research?
By volume in 2022–2025, Peking University publishes the most Bone and Joint Diseases research, followed by Sichuan University and Chinese PLA General Hospital.
By volume, 2022–2025
- 1 Peking UniversityChina 19 works
- 2 Sichuan UniversityChina 15 works
- 3 Chinese PLA General HospitalChina 14 works
- 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 12 works
- 5 Post Graduate Institute of Medical Education and ResearchIndia 12 works
- 6 Shanghai Jiao Tong UniversityChina 11 works
- 7 Harvard UniversityUnited States 11 works
- 8 Charité - Universitätsmedizin BerlinGermany 11 works
- 9 Sun Yat-sen UniversityChina 11 works
- 10 Massachusetts General HospitalUnited States 11 works
Who are the leading researchers in Bone and Joint Diseases?
The most-cited researchers publishing on Bone and Joint Diseases include Cyrus Cooper, David J. Hunter and Flavia Cicuttini.
- 1 Cyrus Cooper United Kingdom 7.2k citations
- 2 David J. Hunter Australia 3.3k citations
- 3 Flavia Cicuttini Australia 3.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Bone and Joint Diseases research done?
The largest centres of Bone and Joint Diseases research in 2022–2025 are Beijing (China), Shanghai (China), Seoul (South Korea) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Shijiazhuang.
Largest cities, 2022–2025
Where it is the local speciality
- ShijiazhuangCN · 21.0 works4.6×
Location quotient: how much more of its research is in Bone and Joint Diseases than the world average.
Where is the best place to study Bone and Joint Diseases?
Among universities, judged by research, Guangzhou University of Chinese Medicine, Sichuan University and Wenzhou Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Guangzhou University of Chinese MedicineChina | 66.4 | 23.4% | 12.8× | 10 | +263.0% |
| 2 | Sichuan UniversityChina | 53.4 | 27.6% | 2.0× | 15 | +143.6% |
| 3 | Wenzhou Medical UniversityChina | 53.2 | 33.7% | 5.6× | 8 | +105.4% |
| 4 | Zhejiang Chinese Medical UniversityChina | 50.8 | 25.3% | 9.4× | 11 | -47.6% |
| 5 | Peking UniversityChina | 49.9 | 16.7% | 2.7× | 19 | +97.5% |
| 6 | Shanghai Jiao Tong UniversityChina | 48.6 | 35.4% | 1.2× | 11 | +69.0% |
| 7 | Nanjing Medical UniversityChina | 43.6 | 33.2% | 3.8× | 8 | +37.0% |
| 8 | Capital Medical UniversityChina | 41.0 | 21.8% | 4.2× | 10 | +68.4% |
| 9 | Harvard UniversityUnited States | 37.6 | 21.7% | 2.0× | 11 | -10.0% |
| 10 | Stanford UniversityUnited States | 36.9 | 29.4% | 1.6× | 9 | +18.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Bone and Joint Diseases research growing?
Output in 2018–2022 was 12% higher than in 2013–2017, peaking in 2020. The fastest-growing topics are Bone and Joint Diseases.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.